XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.24.3

Fair Value Measurements (Tables) | 9 Months Ended
--- | ---
Nov. 02, 2024
Fair Value Disclosures [Abstract] |
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis | The following table presents financial instruments that are measured at fair value on a recurring basis at November 2, 2024, February 3, 2024 and October 28, 2023:
|  | Fair Value Measurements |
(In thousands) |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
As of November 2, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 65,529 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 65,529 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 13,866 |  |  |  | 0 |  |  |  | 0 |  |  |  | 13,866 |
Total |  | $ | 79,395 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 79,395 |
As of February 3, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 91,733 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 91,733 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 12,247 |  |  |  |  |  |  |  |  |  | 12,247 |
Total |  | $ | 103,980 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 103,980 |
As of October 28, 2023 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 53,275 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 53,275 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 11,226 |  |  |  |  |  |  |  |  |  | 11,226 |
Total |  | $ | 64,501 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 64,501 |
Schedule Of Deferred Compensation Plan Liabilities And Related Marketable Securities | The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:
(In thousands) |  | November 2, 2024 |  |  | February 3, 2024 |  |  | October 28, 2023 |
Deferred compensation plan current liabilities |  | $ | 193 |  |  | $ | 114 |  |  | $ | 1,619 |
Deferred compensation plan long-term liabilities |  |  | 13,449 |  |  |  | 11,639 |  |  |  | 9,770 |
Total deferred compensation plan liabilities |  | $ | 13,642 |  |  | $ | 11,753 |  |  | $ | 11,389 |
Marketable securities - mutual funds that fund deferred compensation |  | $ | 13,866 |  |  | $ | 12,247 |  |  | $ | 11,226 |
(In thousands) |  | Thirteen Weeks Ended November 2, 2024 |  |  | Thirteen Weeks Ended October 28, 2023 |  |  | Thirty-nine Weeks Ended November 2, 2024 |  |  | Thirty-nine Weeks Ended October 28, 2023 |
Deferred compensation liabilities |  |  |  |  |  |  |  |  |  |  |  |
Employer contributions, net |  | $ | 83 |  |  | $ | 62 |  |  | $ | 234 |  |  | $ | 233 |
Investment earnings (losses) |  |  | 632 |  |  |  | (1,031 | ) |  |  | 1,214 |  |  |  | (375 | )
Marketable Securities |  |  |  |  |  |  |  |  |  |  |  |
Mark-to-market (gains) losses (1) |  |  | (585 | ) |  |  | 993 |  |  |  | (1,169 | ) |  |  | 376 |
Net deferred compensation expense |  | $ | 130 |  |  | $ | 24 |  |  | $ | 279 |  |  | $ | 234 |
(1) Included in the mark-to-market activity related to equity securities still held at quarter-end, we recognized an unrealized gain of $568,000 and an unrealized loss of $919,000 for the thirteen weeks ended November 2, 2024 and October 28, 2023, respectively, and unrealized gains of $1,118,000 and $141,000 for the thirty-nine weeks ended November 2, 2024 and October 28, 2023, respectively.

X
- Definition Schedule of defered compensation plan liabilities and related marketable securities text block. + References No definition available. + Details
Name: | scvl_ScheduleOfDeferedCompensationPlanLiabilitiesAndRelatedMarketableSecuritiesTableTextBlock
Namespace Prefix: | scvl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration